NCT05763498 Uterine Junctional Zone and Its Relation to Adverse Obstetrical Outcomes in Assisted Reproductive Technology
| NCT ID | NCT05763498 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centro Hospitalar Lisboa Norte |
| Condition | Infertility, Female |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-02-24 |
| Primary Completion | 2025-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2023-02-24 with a primary completion date of 2025-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The junctional zone (JZ) is an internal layer of the myometrium, with unique characteristics that allow its visualization as a hypoechogenic structure in three-dimensional (3D) ultrasound. While there is a growing realization that the origins of major obstetrical complications associated with defective deep placentation, such as pre-term labour, fetal growth restriction and pre-eclampsia, may lie in the very early pregnancy events, the underlying mechanisms are not understood.
Eligibility Criteria
Inclusion Criteria: * Women followed in the infertility clinic aged between 18 and 42 years in cycles of IVF, ICSI or endometrial preparation for frozen embryo transfer Exclusion Criteria: * Myomas * adenomyosis * endometriosis
Contact & Investigator
Isabel B Pereira, M.D
PRINCIPAL INVESTIGATOR
Centro Hospitalar Lisboa Norte
Frequently Asked Questions
Who can join the NCT05763498 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Infertility, Female. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05763498 currently recruiting?
Yes, NCT05763498 is actively recruiting participants. Contact the research team at isabelsofiapereira@yahoo.com for enrollment information.
Where is the NCT05763498 trial being conducted?
This trial is being conducted at Funchal, Portugal, Lisbon, Portugal, Lisbon, Portugal.
Who is sponsoring the NCT05763498 clinical trial?
NCT05763498 is sponsored by Centro Hospitalar Lisboa Norte. The principal investigator is Isabel B Pereira, M.D at Centro Hospitalar Lisboa Norte. The trial plans to enroll 200 participants.